• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.

作者信息

Shah Rahman, Delgado Glenda, Finks Shannon W

机构信息

Section of Cardiology, University of Tennessee, School of Medicine, Memphis, TN, USA.

Veterans Affairs Medical Center, Memphis, TN, USA.

出版信息

Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S66-S68. doi: 10.21037/cdt.2016.11.07.

DOI:10.21037/cdt.2016.11.07
PMID:28748150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509930/
Abstract
摘要

相似文献

1
Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者三联抗栓治疗的持续时间及预后
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S66-S68. doi: 10.21037/cdt.2016.11.07.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的心房颤动患者的三联、双联和单联抗栓治疗。
Cardiovasc Interv Ther. 2020 Jan;35(1):44-51. doi: 10.1007/s12928-019-00600-1. Epub 2019 Jul 8.
4
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.三联疗法：经皮冠状动脉介入治疗的心房颤动患者抗血栓治疗的综述。
J Cardiol. 2019 Jan;73(1):1-6. doi: 10.1016/j.jjcc.2018.09.001. Epub 2018 Oct 4.
5
Triple antithrombotic therapy in patients with atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation.经皮冠状动脉介入治疗术后伴心房颤动患者的三联抗栓治疗。
Am J Health Syst Pharm. 2012 Sep 1;69(17):1485-93. doi: 10.2146/ajhp110556.
6
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的心房颤动患者的三联抗栓治疗。
Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):524-530. doi: 10.1016/j.pcad.2018.01.008. Epub 2018 Feb 3.
7
Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range.三联抗栓治疗是发生大出血并发症的独立预测因素：治疗时间百分比分析。
Circ Cardiovasc Interv. 2013 Aug;6(4):444-51. doi: 10.1161/CIRCINTERVENTIONS.113.000179. Epub 2013 Aug 13.
8
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的患者三联抗栓治疗的持续时间与结局。
JACC Cardiovasc Interv. 2016 Jul 25;9(14):1473-83. doi: 10.1016/j.jcin.2016.04.027.
9
Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓策略
Curr Treat Options Cardiovasc Med. 2019 Feb 7;21(1):3. doi: 10.1007/s11936-019-0705-8.
10
Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.经皮冠状动脉介入治疗后心房颤动合并冠状动脉疾病患者的抗栓治疗方案：聚焦综述
Int J Cardiol. 2017 Sep 15;243:263-269. doi: 10.1016/j.ijcard.2017.05.119. Epub 2017 Jun 2.

引用本文的文献

1
Triple antithrombotic therapy in patients undergoing percutaneous coronary intervention: balancing between ischemia and bleeding.接受经皮冠状动脉介入治疗患者的三联抗栓治疗：缺血与出血之间的平衡
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S128-S130. doi: 10.21037/cdt.2017.04.02.

本文引用的文献

1
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的患者三联抗栓治疗的持续时间与结局。
JACC Cardiovasc Interv. 2016 Jul 25;9(14):1473-83. doi: 10.1016/j.jcin.2016.04.027.
2
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗持续时间的指南聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.
3
Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.对有双重抗血小板治疗（DAPT）临床指征且需长期抗凝治疗的患者，使用或不使用华法林进行双重抗血小板治疗的疗效和安全性评估：一项观察性研究的荟萃分析
Catheter Cardiovasc Interv. 2016 Jul;88(1):E12-22. doi: 10.1002/ccd.26234. Epub 2015 Sep 10.
4
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.药物洗脱支架置入术后需口服抗凝的患者三联治疗的持续时间：ISAR-TRIPLE 试验。
J Am Coll Cardiol. 2015 Apr 28;65(16):1619-1629. doi: 10.1016/j.jacc.2015.02.050.
5
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).急性冠状动脉综合征患者和/或接受经皮冠状动脉介入或瓣膜介入治疗的心房颤动患者的抗栓治疗管理：欧洲心脏病学会血栓形成工作组、欧洲心律协会（EHRA）、欧洲经皮心血管介入协会（EAPCI）和欧洲急性心脏护理协会（ACCA）的联合共识文件，得到心律学会（HRS）和亚太心律学会（APHRS）认可。
Eur Heart J. 2014 Dec 1;35(45):3155-79. doi: 10.1093/eurheartj/ehu298. Epub 2014 Aug 25.
6
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.口服抗凝治疗并行经皮冠状动脉介入治疗的患者中氯吡格雷联合或不联合阿司匹林的应用：一项开放标签、随机、对照试验。
Lancet. 2013 Mar 30;381(9872):1107-15. doi: 10.1016/S0140-6736(12)62177-1. Epub 2013 Feb 13.
7
Triple antithrombotic management after stent implantation: when and how?支架植入术后的三联抗栓治疗：时机与方法？
Heart. 2009 Aug;95(15):1280-5. doi: 10.1136/hrt.2008.160457.
8
Randomized trials or observational tribulations?随机试验还是观察性试验？
N Engl J Med. 2000 Jun 22;342(25):1907-9. doi: 10.1056/NEJM200006223422511.